Nyxoah, S.A. (NYXH) - Multiplikator forward rega marang pendapatan

nyxoah.com (NYXH) - logo korporat

Nyxoah S.A. generates revenue from the sale of implants for patients with apnea who cannot tolerate masks. The projected price-to-sales ratio reflects the dynamics of this demand, with this metric standing at 2.70. Growth is supported by the authority of Genio systems and patent protection for unique nerve stimulators, which create significant barriers to entry for competitors in the neurostimulation segment.

NYXH nyxoah.com: Multiplikator forward rega marang pendapatan ing interval 04.07.2022 - 18.11.2026

Nyxoah - rincian analitis lan metrik utama (NYXH)

- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
Analisis umum perusahaan:NYXH (Nyxoah S.A)
Produk asli nyxoah.com

The forward P/S reflects the ratio of the current market value of Nyxoah S.A. (NYXH) to expected annual sales, allowing for an assessment of the extent to which future growth is priced in. By analyzing the projected P/S value, an investor can determine whether the high valuation is justified by the expansion rates of implantable neurostimulators for the treatment of apnea purchased by clinics and insurance funds.

Analisis perusahaan pesaing

Rasio rega marang prakiraan pendapatan Intuitive Surgical Inc ISRG|Multiplikator Forward P/S Danaher Corporation Inc. DHR|BDX - Rasio rega marang prakiraan pendapatan|STERIS plc (STE) - Multiplikator forward rega marang pendapatan|WST: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Baxter International Inc. (BAX)|MASI (masimo.com) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group Corp STVN|Multiplikator forward rega marang pendapatan TFX (Teleflex Inc)|Merit Medical - Kapitalisasi marang prakiraan pendapatan|Envista Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICUI (ICU Medical Inc)|XRAY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake LeMaitre Corp LMAT|ATRC: Multiplikator Forward P/S|STAA - Rasio kapitalisasi marang dodolan sing dikarepake|NAGE (Chromadex Corp) - Multiplikator Forward P/S|ZimVie Inc (ZIMV) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ANGO|CERS (Cerus Corporation) - Rega forward marang dodolan|Multiplikator Forward P/S TKNO (Alpha Teknova, Inc.)|Monogram Technologies (MGRM) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|STSS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake InfuSystem INFU|Utah Med (UTMD) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan KORU Medical Systems, Inc.|Rasio rega marang prakiraan pendapatan Microbot Medical, Inc.|Kapitalisasi marang prakiraan pendapatan PDEX (Pro-Dex)|Rasio rega marang prakiraan pendapatan Zentek (ZTEK)|Rasio kapitalisasi marang dodolan sing dikarepake Elutia Inc|Multiplikator Forward P/S MLSS (milestonescientific.com)|NXGL: Kapitalisasi marang prakiraan pendapatan|Retractable Tech - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Harvard Bioscience Inc. HBIO|FEMY: Multiplikator Forward P/S|MeihuaMed - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Predictive Oncology Inc|callanjmb.com (CJMB) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Atrion Corporation (ATRI)|Rasio kapitalisasi marang dodolan sing dikarepake neurometrix.com